Entera Bio, Inc.

Entera Bio, Inc. logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2010-01-01
Employees
37
Market Cap
$62.4M
Website
http://www.enterabio.com

Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo

Phase 1
Active, not recruiting
Conditions
Interventions
First Posted Date
2023-07-28
Last Posted Date
2024-11-15
Lead Sponsor
Entera Bio Ltd.
Target Recruit Count
45
Registration Number
NCT05965167
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Clinical Research Center Hadassah Ein Kerem Medical Center, Jerusalem, Israel

A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass

Phase 2
Completed
Conditions
Interventions
First Posted Date
2019-07-01
Last Posted Date
2021-06-28
Lead Sponsor
Entera Bio Ltd.
Target Recruit Count
161
Registration Number
NCT04003467
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel

๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Medical Center, Mt. Scopus Hospital, Jerusalem, Israel

๐Ÿ‡ฎ๐Ÿ‡ฑ

Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel

and more 1 locations

Oral PTH(1-34) PK and PD Study in Patients With Hypoparathyroidism

Phase 2
Completed
Conditions
Interventions
First Posted Date
2018-05-04
Last Posted Date
2019-03-26
Lead Sponsor
Entera Bio Ltd.
Target Recruit Count
20
Registration Number
NCT03516773
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Clinical Research Center Hadassah Ein Kerem Medical Center, Jerusalem, Israel

A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects

First Posted Date
2015-10-08
Last Posted Date
2018-01-10
Lead Sponsor
Entera Bio Ltd.
Target Recruit Count
30
Registration Number
NCT02571140

A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2014-07-29
Last Posted Date
2015-10-07
Lead Sponsor
Entera Bio Ltd.
Target Recruit Count
42
Registration Number
NCT02202603
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

HMO Clinical Research Center Hadassah Ein Kerem Medical Center, Jerusalem, Israel

A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism

First Posted Date
2014-06-02
Last Posted Date
2015-10-07
Lead Sponsor
Entera Bio Ltd.
Target Recruit Count
20
Registration Number
NCT02152228
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Lin Medical Center, Haifa, Israel

ยฉ Copyright 2024. All Rights Reserved by MedPath